Post-chemotherapy pain killer trial begins
Australia | News | By BioSpectrum Bureau | 0 Comment | 11 Dec, 2012
Singapore: Spinifex Pharmaceuticals, an Australian pain drug development company, announced that the first set of patie...Read more
Reva begins trial for bioresorbable scaffold
Australia | News | By BioSpectrum Bureau | 0 Comment | 01 Jul, 2013
Singapore: Australia-based Reva Medical has initiated enrolment of patients for its ReZolve 2 bioresorbable scaffold at ...Read more
CSL files marketing plea for Privigen in Europe
Australia | Regulatory | By BioSpectrum Bureau | 0 Comment | 01 Jun, 2012
Singapore: Australian company CSL Behring has submitted a variation application to the European Medicines Agency (EMA) f...Read more
Australia registers leukaemia drug in benefit scheme
Australia | Regulatory | By BioSpectrum Bureau | 0 Comment | 02 Nov, 2015
Singapore: A treatment for patients with chronic myeloid leukaemia (CML) and Philadelphia chromosome positive acute lymp...Read more
Breast cancer market will rise to $3.4 billion by 2021'
Australia | News | By BioSpectrum Bureau | 0 Comment | 16 Feb, 2016
Singapore: The Asia-Pacific (APAC) breast cancer market is set to experience considerable expansion from $1.9 billion in...Read more
Aspirin use increases risk of age-related eye disease
Australia | News | By BioSpectrum Bureau | 0 Comment | 23 Jan, 2013
Singapore: Researchers at the Centre for Vision Research from the Westmead Millennium Institute for Medical Research (WM...Read more
Orthocell gets patent in Canada
Australia | News | By BioSpectrum Bureau | 0 Comment | 14 Dec, 2015
Singapore: Regenerative medicine company, Orthocell, has been granted a patent in Canada covering the combination of bio...Read more
Australia | News | By BioSpectrum Bureau | 0 Comment | 22 Feb, 2013
Singapore: Bioxyne has entered into a non-binding term sheet for the proposed acquisition of 100 percent of the shares a...Read more
Mid-sized companies are able to achieve much better than big pharma companies in drug development'
Australia | Opinion | By BioSpectrum Bureau | 0 Comment | 19 Jan, 2016
Singapore: Australia-based Clinuvel has developed SCENESSE, its proprietary first-in-class photo protective drug, for in...Read more
Aussie firm gets FDA nod to supply cancer antibody in US labs
Australia | Regulatory | By BioSpectrum Bureau | 2 Comment | 29 May, 2014
Singapore: Sienna Cancer Diagnostics, Melbourne-based biotechnology company focused on developing novel in-vitro diagnos...Read more
Circadian's new diagnosis tech to be launched in July
Australia | News | By BioSpectrum Bureau | 0 Comment | 28 Jun, 2012
Singapore: A novel technology for aiding the diagnosis of Cancers of Unknown Primary (CUP), by Circadian Technologies, w...Read more
Johnson & Johnson in innovation collaboration with the Queensland Government
Australia | News | By BioSpectrum Bureau | 0 Comment | 14 Oct, 2015
Singapore: The Queensland Government has announced a collaboration with the US pharmaceutical and healthcare giant, John...Read more
APAC multiple myeloma market to value $2.8 bn by 2021: Report
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 23 Oct, 2015
Singapore: The treatment market for multiple myeloma across the Asia-Pacific (APAC) countries of China, India, Japan, an...Read more
Aussie anesthetic firm gets patent from 7 nations
Australia | News | By BioSpectrum Bureau | 0 Comment | 29 Oct, 2013
Singapore: Australia-based Drawbridge Pharmaceuticals has been granted patent for its anesthetic formulation Phaxan in t...Read more
Inex iGeneScreen Prenatal Test hits Australia
Australia | News | By BioSpectrum Bureau | 0 Comment | 19 Feb, 2013
Singapore: Singapore's Inex Innovations Exchange, a fetal health diagnostics company, signed a distribution agreement fo...Read more
Mr Mario Pennisi, LifeScience Queensland: Aus govt will provide stimulus amidst slow economy
Australia | Opinion | By BioSpectrum Bureau | 0 Comment | 25 Dec, 2012
There is no doubt that the world is still in a delicate financial balance, with no significant chance of that improving ...Read more
Lignol to invest $1 mn in largest Aus biodiesel plant
Australia | News | By BioSpectrum Bureau | 0 Comment | 26 Aug, 2013
Singapore: Lignol Energy, a leading technology company in the advanced biofuels and renewable chemicals sectors, will in...Read more
Nohla Therapeutics raises $21mn
Australia | News | By BioSpectrum Bureau | 0 Comment | 23 Dec, 2015
Singapore: Nohla Therapeutics, a developer of cellular therapies for haematological disorders and immunological diseases...Read more